TOGETHER FOR BETTER HEALTH

Progress starts
with partnership.

We support innovative, accessible, and affordable solutions to tackle infectious diseases around the world.

DISCOVER OUR FOUNDATION
01
OUR FOUNDATION
WHO WE ARE

Global health challenges demand thoughtful, collaborative action.

The Mueller Health Foundation is a family-led philanthropic organization established in February 2015. We support innovative, accessible and affordable solutions that transform the treatment of health infectious diseases across the globe.

We do this by addressing latency and increased antimicrobial resistance as the underlying core problem.

OUR DIRECTION

Mission
& Vision

MISSION

Advance cures and prevention.

Every life matters! We support research, data collection and analysis, as well as education for the identification, development and implementation of accessible, affordable and effective treatment modalities of lethal infectious diseases around the globe. We have made it our life goal to strive to advance cures and means of prevention.

VISION

A world where treatment is within reach.

Our hope is to live in a world where every person has access to effective treatment options for infectious diseases and infectious diseases ultimately become eradicated.

02
WHAT GUIDES US
OUR VALUES

Principles that move meaningful
work forward.

01

Bold

We believe in innovative solutions and out-of-the-box thinking.

02

Data Oriented

We develop robust monitoring and evaluation frameworks that showcase impact.

03

Open

We foster a collaborative environment where ideas, lessons, and perspectives are shared.

04

Lasting

We build sustainable, scalable solutions that create long-term change.

FOUNDATION TEAM

A small team with a shared
commitment to global health.

PRESIDENT & FOUNDER

Peter Mueller, PhD

With over 30 years of global pharmaceutical and biotechnology experience as a scientist and executive, Dr. Peter Mueller is the President of the Mueller Health Foundation. His career has focused on researching global research and development, drug discovery, and development programs across infectious diseases, immunology, inflammation, cardiovascular diseases, and other therapeutic areas.

Read More
01
DIRECTOR

Ulrike Mueller

Ulrike Mueller serves as a Director for The Mueller Health Foundation. Ulrike has shown a life- long commitment to her passion for finding a cure for infectious diseases. She studied in Ulm, Germany and graduated top of her class to become a medical technician.

In her professional life, she has spent many years working in laboratories at the University of Ulm, Germany to help identify treatments for a wide range of diseases. Ulrike has always had a particular interest in tuberculosis (TB) and is overlooking current program developments at The Mueller Health Foundation.

Read More
02
EXECUTIVE DIRECTOR

Judith Mueller

Judith Mueller serves as the Executive Director for The Mueller Health Foundation. Prior to working for The Mueller Health Foundation, Judith worked at KPMG for the Development and Exempt Organization (DEO) group. 

She focused her time on providing client facing consulting services in the areas of process optimization, grant reviews and grant performance assessments, data analytics and impact measurement, and enterprise risk management for private and corporate foundations, NGOs, and Corporate Citizenship initiatives. She is also the co-creator of KPMG’s Value for Money tool.

Read More
03
TRANSPARENCY

Finance &
Governance

As a private foundation, the Mueller Health Foundation files a Form 990-PF Return of Private Foundation each year with the Internal Revenue Service.

990-Form-2025

990 PF – 2024

990 PF – 2023

990 PF – 2022

990 PF – 2021

990 PF – 2020

990-Form-2018

990-Form-2018

990 PF – 2017

990 PF – 2016

990 PF – 2015

990 PF – 2014

CONNECT & CONTACT

Let’s create
lasting change
together.

We welcome skilled, highly motivated individuals and thoughtful partners who share our commitment to tackling infectious diseases.

info@muellerhealthfoundation.org

Careers

The Mueller Health Foundation is always looking for skilled, highly motivated and entrepreneurial individuals to help us in tackling infectious diseases. If you are interested in joining our team, please submit your resume and contact information to info@muellerhealthfoundation.org.

Peter Mueller, PhD

President, Mueller Health Foundation

With over 30 years of global pharmaceutical and biotechnology experience as a scientist and executive, Dr. Peter Mueller is currently President of the Mueller Health Foundation. Previously, from 2014–2016, he was President of R&D and Chief Scientific Officer of Axcella Health, where he brought several clinical candidates to proof of concept addressing dysregulated amino-acid homeostasis as a root cause for specific metabolic and neurodegenerative diseases.

Prior to Axcella Health, Dr. Mueller served as Executive Vice President, Global Research and Development and Chief Scientific Officer for Vertex Pharmaceuticals from 2003–2014. He provided strategic and operational oversight for Vertex’s worldwide drug discovery and development programs, including clinical, nonclinical and pharmaceutical development, quality assurance, quality control and manufacturing.

His leadership contributed to the successful approval and launch of Incivek® in 2011 and Kalydeco® in 2012, the NDA/MAA submission of Orkambi® in 2014, and several proof-of-clinical-concept candidates across infectious diseases, immune-mediated inflammatory disease, neurodegenerative diseases and cancer.

Before Vertex, he served as Senior Vice President of Research and Development for Boehringer Ingelheim Pharmaceuticals, overseeing global research programs and the development of drug candidates across North and South America, Canada and Japan. He was substantially involved in the development of Spiriva®, Combivent®, Atrovent® and Viramune®.

Dr. Mueller received his undergraduate degree and PhD in Chemistry from the Albert Einstein University of Ulm, Germany, where he also holds a professorship in Theoretical Organic Chemistry. He completed fellowships in Quantum Pharmacology at Oxford University and in Biophysics at the University of Rochester.

His fields of study include synthetic organic chemistry, computational chemistry, RNA biophysics, atherosclerosis research, immune-mediated inflammatory diseases, neurodegenerative diseases, infection, oncology, gene and epigenetic technology, artificial intelligence, and management and business strategy.

He is a member of various scientific and political societies and currently serves on the Board of BioXcel Therapeutics and the US–India Chamber of Commerce Biotech. Among his many honors, he received the prestigious Prix Galien award.

Ulrike Mueller

Director, Mueller Health Foundation

Ulrike Mueller serves as a Director of the Mueller Health Foundation. Ulrike has shown a lifelong commitment to her passion for finding a cure for infectious diseases.

She studied in Ulm, Germany, and graduated at the top of her class to become a medical technician. Throughout her professional career, she spent many years working in laboratories at the University of Ulm, helping identify treatments for a wide range of diseases.

Ulrike has always had a particular interest in tuberculosis and oversees current program developments at the Mueller Health Foundation.

Judith Mueller

Executive Director, Mueller Health Foundation

Judith Mueller serves as Executive Director of the Mueller Health Foundation. Before joining the Foundation, Judith worked in KPMG’s Development and Exempt Organization group.

She provided client-facing consulting services in process optimization, grant reviews and grant-performance assessments, data analytics and impact measurement, and enterprise risk management for private and corporate foundations, nongovernmental organizations and corporate-citizenship initiatives. She is also a co-creator of KPMG’s Value for Money tool.

Before KPMG, Judith served as Director of Monitoring, Evaluation and Impact at Projects for All, a nonprofit organization focused on building internet-enabled, solar-powered computer hubs in remote villages to provide vulnerable communities with access to educational materials and internet connectivity.

Judith holds a Master of International Affairs from Columbia University’s School of International and Public Affairs and a Master in Quantitative Methods in the Social Sciences from Columbia University’s Graduate School of Arts and Sciences. During her time at Columbia, she completed a fellowship with NASA and worked in the Energy and Environment Bureau at UNDP, with a focus on least-developed countries.

She also consulted Small Island Developing States on the creation and implementation of a sustainable-energy fund. Judith graduated summa cum laude with a BA and departmental honors in International Economics and International Affairs from George Washington University’s Elliott School of International Affairs. She spent a year at Oxford University studying economics and completed executive education focused on blockchain and artificial-intelligence technologies at MIT.